Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

NCT ID: NCT05837208

Last Updated: 2023-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

26 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-04

Study Completion Date

2022-04-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to determine:

* the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
* the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
* the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a monocentric, comparative, open study performed on the face and forearms of healthy adults.

Planning of the visits:

Visit 1: Inclusion visit (D1) Visit 2: End of study visit (D10), a window of +/- 2 days is allowed for this evaluation, \* The theoretical study duration for each subject is 10 days. The maximal study duration for each subject is 12 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sunscreen

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treated Group

all subjects will apply the study product RV4369A

RV4369A cosmetic product

Intervention Type OTHER

The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer.

Application modalities:

Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits.

After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits.

Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities.

After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RV4369A cosmetic product

The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer.

Application modalities:

Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits.

After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits.

Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities.

After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Dry, normal to combination skin
* Phototype I to V inclusive.
* Absence of significant facial hair.

Exclusion Criteria

Population

* Pregnant, breastfeeding women.
* For men: moustached or bearded.
* Substantial hair on the forearm and face.
* Application of keratolytic or self-tanning products to the face, forearms and arms in the four weeks prior to inclusion.
* With scars or other cutaneous characteristics, sunburn on forearms in the test areas, the size of which is considered incompatible with the study.
* Application of water, cleansing or beauty products to the forearms and arms since the last wash on the evening before inclusion.

Diseases :

* Known history of allergy to any of the investigational product ingredients.
* Known history of allergy to latex.
* Skin lesions or skin disease on the face or on the arms and forearms that may affect test results (seborrheic dermatitis, atopic dermatitis, psoriasis, acne, rosacea, etc.).

Treatments:

* Ongoing local or Oral treatment (retinoids, anti-inflammatory) that may affect test results.
Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pierre Fabre Dermo Cosmetique

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thérèse Nocera, MD

Role: PRINCIPAL_INVESTIGATOR

Pierre Fabre Dermo Cosmetique

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Skin Research Center

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ADPROTECTPF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.